(BW) Babcock & Wilcox Enterprises - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05614L2097

Boilers, Emissions Control, Waste-To-Energy, Hydrogen, Aftermarket Services

Dividends

Currently no dividends paid
Risk via 10d forecast
Volatility 130%
Value at Risk 5%th 181%
Relative Tail Risk -15.49%
Reward TTM
Sharpe Ratio 1.44
Alpha 188.32
CAGR/Max DD 0.07
Character TTM
Hurst Exponent 0.563
Beta 2.742
Beta Downside 3.649
Drawdowns 3y
Max DD 96.07%
Mean DD 57.46%
Median DD 73.81%

Description: BW Babcock & Wilcox Enterprises November 14, 2025

Babcock & Wilcox Enterprises (NYSE: BW) delivers energy and emissions-control solutions across industrial, utility, municipal and international markets through three operating segments: Renewable, Environmental and Thermal. The Renewable segment focuses on waste-to-energy, hydrogen generation (BrightLoop) and biomass-based power (OxyBright), while the Environmental segment supplies nitrogen-oxide, sulfur-dioxide, mercury and carbon-capture technologies for a range of fuels. The Thermal segment provides aftermarket services, engineered upgrades and a portfolio of steam-generation boilers for power, oil-&-gas, petrochemical and heavy-industry customers.

Key metrics (FY 2023) show BW generated roughly $2.2 billion in revenue, with the Renewable segment contributing about 22 % and posting a 7 % higher year-over-year growth rate than the Thermal segment, reflecting accelerating demand for circular-economy solutions. The global waste-to-energy market is projected to expand at a CAGR of ~6 % through 2030, driven by stricter landfill regulations and carbon-pricing policies in the U.S., Europe and Southeast Asia-regions where BW already has a footprint.

Analysts should watch BW’s capital-expenditure plans for its OxyBright and BrightLoop platforms, as well as any policy shifts in the U.S. Inflation Reduction Act that could unlock additional subsidies for hydrogen and biomass projects. For a deeper, data-driven assessment of BW’s valuation and risk profile, a look at the ValueRay analytics platform can provide useful benchmarks and scenario analysis.

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (-108.5m TTM) > 0 and > 6% of Revenue (6% = 32.4m TTM)
FCFTA -0.16 (>2.0%) and ΔFCFTA -3.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 14.56% (prev 27.82%; Δ -13.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA -0.13 (>3.0%) and CFO -88.4m > Net Income -108.5m (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 1.20 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (103.0m) change vs 12m ago 11.59% (target <= -2.0% for YES)
Gross Margin 26.76% (prev 23.80%; Δ 2.96pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 73.92% (prev 103.8%; Δ -29.85pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -0.79 (EBITDA TTM -22.1m / Interest Expense TTM 41.4m) >= 6 (WARN >= 3)

Altman Z'' -9.97

(A) 0.12 = (Total Current Assets 479.7m - Total Current Liabilities 401.0m) / Total Assets 657.9m
(B) -2.59 = Retained Earnings (Balance) -1.70b / Total Assets 657.9m
warn (B) unusual magnitude: -2.59 — check mapping/units
(C) -0.04 = EBIT TTM -32.8m / Avg Total Assets 731.3m
(D) -1.92 = Book Value of Equity -1.71b / Total Liabilities 890.1m
Total Rating: -9.97 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 14.97

1. Piotroski 2.0pt
2. FCF Yield -9.97%
3. FCF Margin -18.88%
4. Debt/Equity -2.00
5. Debt/Ebitda -12.37
6. ROIC - WACC (= -58.92)%
7. RoE 38.46%
8. Rev. Trend -45.65%
9. EPS Trend -30.74%

What is the price of BW shares?

As of December 10, 2025, the stock is trading at USD 6.29 with a total of 3,569,612 shares traded.
Over the past week, the price has changed by +0.64%, over one month by -8.84%, over three months by +212.94% and over the past year by +212.94%.

Is BW a buy, sell or hold?

Babcock & Wilcox Enterprises has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold BW.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the BW price?

Issuer Target Up/Down from current
Wallstreet Target Price 8.3 32.4%
Analysts Target Price 8.3 32.4%
ValueRay Target Price 7.3 16.2%

BW Fundamental Data Overview December 06, 2025

Market Cap USD = 749.9m (749.9m USD * 1.0 USD.USD)
P/E Forward = 140.8451
P/S = 1.0397
P/B = 60.5649
P/EG = -0.08
Beta = 1.445
Revenue TTM = 540.5m USD
EBIT TTM = -32.8m USD
EBITDA TTM = -22.1m USD
Long Term Debt = 247.9m USD (from longTermDebt, last quarter)
Short Term Debt = 173.7m USD (from shortTermDebt, last quarter)
Debt = 463.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 273.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.02b USD (749.9m + Debt 463.5m - CCE 189.9m)
Interest Coverage Ratio = -0.79 (Ebit TTM -32.8m / Interest Expense TTM 41.4m)
FCF Yield = -9.97% (FCF TTM -102.0m / Enterprise Value 1.02b)
FCF Margin = -18.88% (FCF TTM -102.0m / Revenue TTM 540.5m)
Net Margin = -20.07% (Net Income TTM -108.5m / Revenue TTM 540.5m)
Gross Margin = 26.76% ((Revenue TTM 540.5m - Cost of Revenue TTM 395.9m) / Revenue TTM)
Gross Margin QoQ = 24.90% (prev 30.02%)
Tobins Q-Ratio = 1.56 (Enterprise Value 1.02b / Total Assets 657.9m)
Interest Expense / Debt = 1.83% (Interest Expense 8.50m / Debt 463.5m)
Taxrate = -76.92% (out of range, set to none) (1.00m / -1.30m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.20 (Total Current Assets 479.7m / Total Current Liabilities 401.0m)
Debt / Equity = -2.00 (negative equity) (Debt 463.5m / totalStockholderEquity, last quarter -232.2m)
Debt / EBITDA = -12.37 (negative EBITDA) (Net Debt 273.6m / EBITDA -22.1m)
Debt / FCF = -2.68 (negative FCF - burning cash) (Net Debt 273.6m / FCF TTM -102.0m)
Total Stockholder Equity = -282.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -16.49% (Net Income -108.5m / Total Assets 657.9m)
RoE = 38.46% (negative equity) (Net Income TTM -108.5m / Total Stockholder Equity -282.1m)
RoCE = 96.09% (negative capital employed) (EBIT -32.8m / Capital Employed (Equity -282.1m + L.T.Debt 247.9m))
RoIC = -48.96% (negative operating profit) (EBIT -32.8m / (Assets 657.9m - Curr.Liab 401.0m - Cash 189.9m))
WACC = 9.96% (E(749.9m)/V(1.21b) * Re(16.12%) + (debt cost/tax rate unavailable))
Discount Rate = 16.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.34%
Fair Price DCF = unknown (Cash Flow -102.0m)
EPS Correlation: -30.74 | EPS CAGR: -6.27% | SUE: -0.04 | # QB: 0
Revenue Correlation: -45.65 | Revenue CAGR: -6.58% | SUE: -0.06 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.01 | Chg30d=+0.055 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.03 | Chg30d=+0.110 | Revisions Net=+1 | Growth EPS=+91.4% | Growth Revenue=+4.9%

Additional Sources for BW Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle